Login / Signup

Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods.

Georgios E ChristakopoulosKendra N WalkerJesse SmithClifford M TakemotoYan ZhengChing-Hong PuiRaul C RibeiroLei WangStanley B PoundsJeffrey E RubnitzHiroto Inaba
Published in: Cancer (2023)
LD-cytarabine treatment appears to be a safe and effective means of cytoreduction for children with AML and hyperleukocytosis.
Keyphrases
  • acute myeloid leukemia
  • newly diagnosed
  • young adults
  • allogeneic hematopoietic stem cell transplantation
  • high dose
  • metabolic syndrome
  • glycemic control